Platelet von Willebrand factor (VWF) MRNA analysis in patients with von Willebrand disease (VWD) and null mutations in VWF gene

被引：0
|
作者：
Giacomelli, S. [1 ]
Rodeghiero, F. [1 ]
Castaman, G. [1 ]
机构：
[1] San Bortolo Hosp, Dept Cellular Therapy & Hematol, Vicenza, Italy
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-WE-626
引用
收藏
页码：839 / 839
页数：1
相关论文
共 50 条
  • [21] Skin testing, graded challenge, and desensitization to von Willebrand factor (VWF) products in type III von Willebrand disease (VWD)
    Platt, Craig D.
    D'Angelo, Loren
    Neufeld, Ellis J.
    Broyles, Ana Dioun
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2016, 4 (05): : 1006 - 1008
  • [22] Multiple mutations in VWF gene of boy with severe von Willebrand disease
    Surdhar, GK
    Enayat, MS
    Lawson, S
    Williams, MD
    Hill, FGH
    THROMBOSIS AND HAEMOSTASIS, 1999, : 583 - 583
  • [23] Skin Testing, Graded Challenge and Desensitization to Von Willebrand Factor (vWF) Products in Type III Von Willebrand Disease (VWD)
    Platt, Craig D.
    D'Angelo, Loren
    Neufeld, Ellis J.
    Broyles, Ana Dioun
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB121 - AB121
  • [24] Efficacy of emicizumab in von Willebrand disease (VWD) patients with and without alloantibodies to von Willebrand factor (VWF): Report of two cases and review of literature
    Shanmukhaiah, Chandrakala
    Jijina, Farah
    Kannan, S.
    Pai, Nanda G.
    Kulkarni, Bipin
    Khuba, Santosh, V
    Shaikh, Madiha
    Joshi, Aditi
    Phatale, Rajesh
    Apte, Shashikant
    HAEMOPHILIA, 2022, 28 (02) : 286 - 291
  • [25] Comparison between plasma von Willebrand factor (VWF) and VWF antigen II level in normal individuals and patients with von Willebrand disease
    DeRomeuf, C
    Mazurier, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 640 - 640
  • [26] Evaluating Performance of Contemporary and Historical von Willebrand Factor (VWF) Assays in the Laboratory Identification of von Willebrand Disease (VWD): The Australasian Experience
    Favaloro, Emmanuel J.
    Dean, Elysse
    Arunachalam, Sandya
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2022, 48 (06): : 711 - 731
  • [27] Two unrelated von willebrand disease (VWD) type 2A (IIE) families caused by skipping of exon 26 on the von willebrand factor (VWF) mRNA
    Baronciani, L.
    Garcia-Oya, I
    Solimando, M.
    La Marca, S.
    Cozzi, G.
    Stufano, F.
    Canciani, Teresa M.
    Peyvandi, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 913 - 913
  • [28] INTERPLAY OF VON-WILLEBRAND-FACTOR (VWF) MUTATIONS ON GPIB-BINDING AND F-VIII-BINDING VARIANTS OF VON-WILLEBRAND DISEASE (VWD)
    ROCK, AL
    KRONER, PA
    FAHS, S
    KLUESSENDORF, M
    FRIEDMAN, KD
    MONTGOMERY, RR
    BLOOD, 1993, 82 (10) : A339 - A339
  • [29] Pharmacokinetics of von Willebrand factor (human) in patients with von Willebrand disease (vWD)
    Menache, D
    Aronson, DL
    Kennedy, D
    Montgomery, RR
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2097 - P2097
  • [30] MOLECULAR ALTERATIONS OF FACTOR VIII VON WILLEBRAND FACTOR (F-VIII-VWF) IN VON WILLEBRANDS DISEASE (VWD)
    GRALNICK, HR
    COLLER, BS
    SULTAN, Y
    THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1975, 34 (03): : 902 - 902
12345